ARCA biopharma, Inc.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1992-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.arcabio.com
Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19
- First Posted Date
- 2020-12-07
- Last Posted Date
- 2023-02-21
- Lead Sponsor
- ARCA Biopharma, Inc.
- Target Recruit Count
- 160
- Registration Number
- NCT04655586
- Locations
- 🇺🇸
ARCA Investigational Site #120, Tucson, Arizona, United States
🇦🇷ARCA Investigational Site #112, Rosario, Sante Fe, Argentina
🇦🇷ARCA Investigational Site #127, San Nicolás, Buenos Aires, Argentina
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
- Conditions
- Interventions
- First Posted Date
- 2013-10-28
- Last Posted Date
- 2022-09-26
- Lead Sponsor
- ARCA Biopharma, Inc.
- Target Recruit Count
- 267
- Registration Number
- NCT01970501
- Locations
- 🇺🇸
ARCA Clinical Research Site #196, Puyallup, Washington, United States
🇺🇸ARCA Clinical Research Site #151, Columbus, Ohio, United States
🇺🇸ARCA Clinical Research Site #153, Aurora, Colorado, United States
Study of NU172 as Anticoagulation in Patients Undergoing Off-pump CABG Surgery
- Conditions
- First Posted Date
- 2008-12-16
- Last Posted Date
- 2011-06-10
- Lead Sponsor
- ARCA Biopharma, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT00808964
Phase 2 Proof-of-Concept Study of the Safety and Efficacy of Alfimeprase to Rapidly Open Arteries and Restore Brain Function Following a Stroke
- First Posted Date
- 2007-07-12
- Last Posted Date
- 2008-04-24
- Lead Sponsor
- ARCA Biopharma, Inc.
- Target Recruit Count
- 7
- Registration Number
- NCT00499902
- Locations
- 🇨🇦
University of Calgary, Foothills Medical Centre, Calgary, Alberta, Canada
🇨🇦Vancouver General Hospital, Vancouver, British Columbia, Canada
🇨🇦Montreal Neurological Institute, Montreal, Quebec, Canada
Safety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon Cancer
- Conditions
- First Posted Date
- 2007-03-06
- Last Posted Date
- 2008-05-07
- Lead Sponsor
- ARCA Biopharma, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT00443573
- Locations
- 🇺🇸
LAC/USC Medical Center, Los Angeles, California, United States
Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central Catheters
- Conditions
- First Posted Date
- 2006-06-30
- Last Posted Date
- 2008-08-14
- Lead Sponsor
- ARCA Biopharma, Inc.
- Target Recruit Count
- 300
- Registration Number
- NCT00346424
- Locations
- 🇺🇸
Corvallis Clinic, Corvallis, Oregon, United States
Study of Alfimeprase's Ability to Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery
- Conditions
- First Posted Date
- 2006-06-20
- Last Posted Date
- 2008-01-15
- Lead Sponsor
- ARCA Biopharma, Inc.
- Target Recruit Count
- 300
- Registration Number
- NCT00338585
- Locations
- 🇺🇸
Montefiore Medical Center, Bronx, New York, United States
Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters
- Conditions
- First Posted Date
- 2006-05-05
- Last Posted Date
- 2008-08-15
- Lead Sponsor
- ARCA Biopharma, Inc.
- Registration Number
- NCT00322270
- Locations
- 🇺🇸
Mercy Hospital, Miami, Florida, United States
🇺🇸Hematology/Oncology Consultants, Inc., Columbus, Ohio, United States
🇺🇸Cancer Research & Prevention Center, Soquel, California, United States
Anticoagulation With rNAPc2 to Eliminate MACE/TIMI 32
- Conditions
- First Posted Date
- 2005-06-27
- Last Posted Date
- 2006-11-29
- Lead Sponsor
- ARCA Biopharma, Inc.
- Target Recruit Count
- 300
- Registration Number
- NCT00116012
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Study of Alfimeprase to Rapidly Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery on Leg Arteries
- Conditions
- First Posted Date
- 2005-06-27
- Last Posted Date
- 2008-01-15
- Lead Sponsor
- ARCA Biopharma, Inc.
- Target Recruit Count
- 300
- Registration Number
- NCT00115999
- Locations
- 🇺🇸
The Cleveland Clinic Foundation, Cleveland, Ohio, United States